IDEXX LABORATORIES INC /DE Income Taxes Paid
IDEXX LABORATORIES INC /DE (IDXX) reported Income Taxes Paid of $90.92 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2024-08-06
- IDEXX LABORATORIES INC /DE income taxes paid for the quarter ending 2024-06-30 was $77.69M, a 13.61% decline year-over-year.
- IDEXX LABORATORIES INC /DE income taxes paid for the quarter ending 2024-03-31 was $13.23M, a 83.79% increase year-over-year.
- IDEXX LABORATORIES INC /DE income taxes paid for the quarter ending 2023-09-30 was $63.73M, a 24.01% increase year-over-year.
- IDEXX LABORATORIES INC /DE income taxes paid for the quarter ending 2023-06-30 was $89.93M, a 23.09% decline year-over-year.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month |
|---|---|---|---|
| 2024-06-30 | $77.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $90.92M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $13.23M 10-Q · filed 2024-05-01 | ||
| 2023-09-30 | $63.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $153.66M derived: sum of 2 quarters · filed 2024-08-06 | $160.86M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $89.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $97.13M 10-Q · filed 2024-08-06 | |
| 2023-03-31 | $7.20M 10-Q · filed 2024-05-01 | ||
| 2022-09-30 | $51.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $168.32M derived: sum of 2 quarters · filed 2023-11-01 | $179.72M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $116.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $128.32M 10-Q · filed 2023-08-01 | |
| 2022-03-31 | $11.40M 10-Q · filed 2023-05-02 | ||
| 2021-09-30 | $14.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $83.93M derived: sum of 2 quarters · filed 2022-11-01 | $96.10M 10-Q · filed 2022-11-01 |
| 2021-06-30 | $69.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $81.92M 10-Q · filed 2022-08-02 | |
| 2021-03-31 | $12.17M 10-Q · filed 2022-05-04 | ||
| 2020-09-30 | $49.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $67.89M derived: sum of 2 quarters · filed 2021-11-02 | $79.91M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $17.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $29.98M 10-Q · filed 2021-07-30 | |
| 2020-03-31 | $12.02M 10-Q · filed 2021-05-04 | ||
| 2019-09-30 | $23.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $71.32M derived: sum of 2 quarters · filed 2020-10-29 | $80.04M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $48.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $56.95M 10-Q · filed 2020-07-31 | |
| 2019-03-31 | $8.72M 10-Q · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |